Project Grant HT94252510460
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$292K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Detroit, MI 48202, USA
Similar Awards
This federal Project Grant award of $714,934 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by the Henry Ford Health System in Detroit, Michigan to investigate the link between pancreatic neoplasia and carcinoma. The project will be conducted over a 3-year period from July 1, 2025 to June 30, 2028. As a non-profit integrated healthcare provider and research organization, Henry Ford Health System...
The Defense Health Agency awarded a $523,663 Project Grant to the Henry Ford Health System - doing business as Henry Ford Hospital, a non-profit hospital in Detroit, Michigan. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), supports research to investigate the NETRIN G1 ligand as a new immunomodulatory target and early biomarker in pancreatic cancer. The project will be conducted from August 1, 2023 to July 31, 2026. Henry Ford Health System has...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $532,000.00 in funding to the Henry Ford Health System in Detroit, MI. The grant supports research to investigate HDAC3 as a potential therapeutic target for Langerhans cell histiocytosis, a rare medical condition. The performance period for this grant runs from December 1, 2024 to November 30, 2027. As a prominent non-profit...
The Henry Ford Health System was awarded a $615,782 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 15, 2022 to July 14, 2025 to investigate paracrine pathways contributing to the growth and invasion of neurofibromas and the role of the cellular microenvironment. Through this research, the awardee aims to advance understanding of medical solutions for neurofibromas,...
This $911,999 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research by the Henry Ford Health System in Detroit, Michigan to target mitochondrial metabolism in ovarian cancer. The award, effective April 1, 2024 through March 31, 2028, will support basic, translational, and clinical research aimed at developing new treatments, diagnostic tools, and preventive measures for this area of military medical importance....
Henry Ford Hospital will receive $1.1 million from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct the project "TRIBBLES 2, A NOVEL TARGET FOR THERAPY OF ENZALUTAMIDE-RESISTANT NEUROENDOCRINE PROSTATE CANCER" from September 1, 2022 through August 31, 2025. This project aims to investigate medical solutions for prostate cancer through basic, applied, and advanced biomedical research focused on developing new...
The Department of the Army Medical Command awarded a $520,751 Project Grant to the Veteran Research And Education Foundation Of ST Louis through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 1, 2022 to July 31, 2026 to improve outcomes for prostate cancer patients based on comorbidities, with the goal of developing personalized medicine approaches. Through this award, the Foundation will conduct research to investigate medical...
The Defense Health Agency awarded a $607,377 Project Grant to the Regents of the University of Michigan to fund a 2-year research project titled "A NEW IDEA FOR ADVANCING AXITINIB-BASED THERAPY IN RECURRENT AND METASTATIC HNSCC." This grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. The University of Michigan, a leading...
The Department of the Army Medical Command awarded a $776,293 Project Grant to Albert Einstein College of Medicine to control the burden of metastatic disease in pancreatic ductal adenocarcinoma. The grant was awarded on September 15, 2022 under the Military Medical Research and Development program (CFDA 12.420) and will run through September 14, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
The Department of the Army Medical Command awarded a $1,080,268 project grant to Health Research-Roswell Park Cancer Institute Division through the Military Medical Research and Development program (CFDA 12.420). The grant funding will support research efforts to target stress pathways in esophagus cancer in order to boost anti-tumor immunity, promote response to therapy, and prolong patient survival. By investigating medical solutions at the molecular level, this research aims to transform...